David P. Elder, Ph.D

Antimicrobial Preservatives Part Three: Challenges Facing Preservative Systems
Friday, December 22, 2017
The third and final article in this series deals with the many external challenges that face formulators who are developing preservation systems for multi-use oral, topical and parenteral medicinal products. read more
Solubility in Pharmaceutical R&D: Predictions and Reality
Thursday, February 20, 2014
Lipinski’s seminal paper on experimental and computational (in silico) methods to estimate the solubility and permeability of drug candidates was published just over 15-years ago. read more
Antimicrobial Preservatives Part Three: Challenges Facing Preservative Systems
Sunday, January 01, 2012
The third article in this series deals with the many external challenges that face the pharmaceutical scientist tasked with developing preservation systems for multi-use oral, topical and parenteral medicinal products. read more
Antimicrobial Preservatives Part Two: Choosing a Preservative
Sunday, January 01, 2012
Introduction: The second article in this series deals with the many constraints that face the pharmaceutical scientist tasked with developing preservation systems for multi-use oral, topical and parenteral medicinal products... read more
Antimicrobial Preservatives Part One: Choosing a Preservative System
Sunday, January 01, 2012
Introduction: Excipients are included in medicinal products to facilitate manufacture, consumption or administration, or to enhance stability/absorption. They can also facilitate product differentiation, enhance aesthetic ... read more
Effective Formulation Development Strategies for Poorly Soluble Active Pharmaceutical Ingredients (APIs)
Friday, October 01, 2010
One of the least desired outcomes of utilizing combinatorial and high throughput chemistry has been a marked increase in poorly soluble drug candidates [1]. The number of poorly soluble new drugs entering development has been... read more